Nandita deSouza* speaks to Nick Ward, Commissioning Editor:
Nandita deSouza speaks about her involvement in the development of high-frequency ultrasound (HiFU) for the treatment of cancer-related pain.Nandita deSouza is a Professor of translational imaging at The Institute of Cancer Research, (ICR, London, UK) and Honorary Consultant at The Royal Marsden Hospital (London, UK). N deSouza is a codirector of the Cancer Research UK Clinical Magnetic Resonance Research Group at the ICR. In this role she coordinates multidisciplinary research projects involving clinical medicine, physics, biochemistry and engineering that are aimed at improving patient care.
Disclaimer
The opinions expressed in this interview are those of the interviewees and do not necessarily reflect the views of Future Medicine Ltd.
Financial & competing interests disclosure
N deSouza receives support from Cancer Research UK who fund a 5-year Imaging Centre grant at ICR, the NIHR who fund a Clinical Research Facility in Imaging at the Royal Marsden Hospital, The EU iMi QuIC ConCePT project and the Focused Ultrasound Foundation who have established a Centre of Excellence at ICR. N deSouza has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.